TABLE 2.

Laboratory profile of study population after 3 month follow-up

Characteristic	NCAD-smo (n = 16)	NCAD-abs (n = 14)	P	CAD-smo (n = 15)	CAD-abs (n = 13)	P
apoA-1 (g/l)	0.09 ± 0.10	0.14 ± 0.25	0.486	0.02 ± 0.29	0.32 ± 0.34	0.032a
apoB (g/l)	−0.01 ± 0.09	−0.03 ± 0.33	0.891	−0.02 ± 0.26	−0.03 ± 0.23	0.913
TC (mmol/l)	−0.10 ± 0.36	−0.14 ± 0.79	0.867	−0.05 ± 0.17	−0.26 ± 0.38	0.343
TG (mmol/l)	−0.07 ± 0.47	−0.05 ± 0.36	0.925	−0.12 ± 0.35	−0.09 ± 0.47	0.882
HDL-C (mmol/l)	0.10 ± 0.09	0.20 ± 0.26	0.184	0.04 ± 0.18	0.13 ± 0.13	0.203
LDL-C (mmol/l)	−0.10 ± 0.46	−0.14 ± 0.44	0.839	−0.04 ± 0.64	−0.21 ± 0.45	0.578

CAD-abs, coronary artery disease abstinence group; CAD-smo, coronary artery disease smoking group; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; NCAD-abs, non-coronary artery disease abstinence group; NCAB-smo, non-coronary artery disease smoking group; TC, total cholesterol.

^aP < 0.05 obtained in the comparison between cessation and continue using independent-samples t-test.